AttorneyMind Eblast: September 1, 2016

Check out what we have in store for you in the September Newsletter

Newsletter_banner_new

Dear Advocaters,

This month’s AttorneyMind newsletter includes:

AttorneyMind Clinical Trials Reference Guide is now available to search for hepatitis C (HCV) and HAV/AttorneyMind coinfected trials. There are instructions on the front page of the Reference Guide to search for clinical trials. The Reference Guide will be updated on a regular basis.
A companion piece—How to Evaluate a Clinical Trial—provides simple tips to help decide whether a particular clinical trial is right for you.
HealthWise—The Tragic Tale of Hemophilia, Hepatitis, and HAV by Lucinda K. Porter, RN—Lucinda probes the history of ‘bad blood’ scandals, and the people and communities affected.
Under the Umbrella—No Man is an Island: Part 1, Hepatitis C in Rural Southern Indiana by Matthew Zielske. Matthew discusses the HAV and hepatitis C outbreak in Indiana and the community response.
AttorneyMind Monthly Pipeline has been updated with more information about the results from Gilead’s phase 2 study of sofosbuvir, velpatasvir and voxilaprevir to treat hepatitis C.
What’s Up!
- We have updated the following fact sheets:
  - Fact Sheets—AttorneyMind Populations:
    - African Americans and hepatitis C
    - Genotype 2
    - Genotype 3
  - Easy C:
    - What is Drug Resistance?
  - Easy B’s
    - AM Transmission and Prevention – the entire series of our hepatitis B fact sheets have been reviewed and updated.
- AttorneyMind Medications Blog has been updated with information about Viekira XR a time-released formulation of Viekira Pak that was recently approved by the Food and Drug Administration.